Literature DB >> 17525829

Inhibition of galectin-3 mediated cellular interactions by pectic polysaccharides from dietary sources.

U V Sathisha1, Smitha Jayaram, M A Harish Nayaka, Shylaja M Dharmesh.   

Abstract

Pectic polysaccharides from dietary sources such as Decalepis hamiltonii--swallow root (SRPP), Hemidesmus indicus (HPP), Nigella sativa--black cumin (BCPP), Andrographis serpyllifolia-(APP), Zingiber officinale--ginger (GRPP) and, citrus pectin (CPP) were examined for galectin inhibitory activity. Inhibition of (a) galectin-3 of MDA-MB-231 cells induced hemagglutination of red blood cells; (b) galectin-3 mediated interaction between normal/metastatic human buccal cells (NBC)/(MBC) and; (c) invasion of MDA-MB-231 and MBC in the invasive chamber was assessed. Results indicated that SRPP inhibited hemagglutination at Minimum Inhibitory Concentration (MIC) of 1.86 microg ml(-1) equivalent of carbohydrate as apposed to those of BCPP (130 microg ml(-1)), APP (40 microg ml(-1)), HPP (40 microg ml(-1)) and CPP (25 microg ml(-1)). GRPP even at concentration >1-6 mg ml(-1) did not inhibit agglutination. Also SRPP showed approximately 15 and 2 fold potent anti hemagglutination activity relative to that of galectin-3 specific sugars-galactose (MIC-27.1 microg ml(-1)) and lactose (MIC-4.16 microg ml(-1)) respectively. Further, SRPP at 10 microg ml(-1) inhibited agglutination of NBC by galectin-3 of MDA-MB-231 cells. Modified swallow root pectic polysaccharide (MSRPP) of 50 kDa retained anti hemagglutination activity (MIC of 1.03 microg ml(-1)) and inhibited MDA-MB-231 and MBC invasion by 73 and 50% with an IC(50) of 136 and 200 microg ml(-1) respectively. Both SRPP and MSRPP induced apoptosis up to 80% at 100 microg ml(-1) concentration by activating approximately 2 and 8 folds of Caspase-3 activity. Sugar composition analysis and its correlation with the galectin inhibitory property indicated that pectic polysaccharides with higher arabinose and galactose content-arabinogalactan inhibited hemagglutination significantly.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17525829     DOI: 10.1007/s10719-007-9042-3

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  37 in total

Review 1.  An overview of the epidemiological evidence linking diet and cancer.

Authors:  R Doll
Journal:  Proc Nutr Soc       Date:  1990-07       Impact factor: 6.297

2.  Reevaluation of the phenol-sulfuric acid reaction for the estimation of hexoses and pentoses.

Authors:  P Rao; T N Pattabiraman
Journal:  Anal Biochem       Date:  1989-08-15       Impact factor: 3.365

3.  Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin.

Authors:  Pratima Nangia-Makker; Victor Hogan; Yuichiro Honjo; Sara Baccarini; Larry Tait; Robert Bresalier; Avraham Raz
Journal:  J Natl Cancer Inst       Date:  2002-12-18       Impact factor: 13.506

Review 4.  Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis.

Authors:  A Raz; R Lotan
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

5.  TNF-alpha-induced apoptosis in human naïve and memory CD8+ T cells in aged humans.

Authors:  Sudhir Gupta; Sastry Gollapudi
Journal:  Exp Gerontol       Date:  2005-11-14       Impact factor: 4.032

6.  Bile acid hydrophobicity is correlated with induction of apoptosis and/or growth arrest in HCT116 cells.

Authors:  A A Powell; J M LaRue; A K Batta; J D Martinez
Journal:  Biochem J       Date:  2001-06-01       Impact factor: 3.857

7.  Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9.

Authors:  J Ochieng; R Fridman; P Nangia-Makker; D E Kleiner; L A Liotta; W G Stetler-Stevenson; A Raz
Journal:  Biochemistry       Date:  1994-11-29       Impact factor: 3.162

8.  Galectin-3, a beta-galactoside-binding animal lectin, is a marker of anaplastic large-cell lymphoma.

Authors:  K N Konstantinov; B A Robbins; F T Liu
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

Review 9.  Galectin-3 and metastasis.

Authors:  Yukinori Takenaka; Tomoharu Fukumori; Avraham Raz
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

10.  Arabinogalactan blockade of experimental metastases to liver by murine hepatoma.

Authors:  B Hagmar; W Ryd; H Skomedal
Journal:  Invasion Metastasis       Date:  1991
View more
  16 in total

1.  The inhibitory effects of a rhamnogalacturonan I (RG-I) domain from ginseng pectin on galectin-3 and its structure-activity relationship.

Authors:  Xiaoge Gao; Yuan Zhi; Lin Sun; Xiaoxia Peng; Tao Zhang; Huiting Xue; Guihua Tai; Yifa Zhou
Journal:  J Biol Chem       Date:  2013-10-07       Impact factor: 5.157

2.  Antimetastatic pectic polysaccharide from Decalepis hamiltonii; galectin-3 inhibition and immune-modulation.

Authors:  Sathisha U Venkateshaiah; Mallikarjuna S Eswaraiah; Harish Nayaka M Annaiah; Shylaja M Dharmesh
Journal:  Clin Exp Metastasis       Date:  2017-02-03       Impact factor: 5.150

3.  The carbohydrate-binding domain on galectin-1 is more extensive for a complex glycan than for simple saccharides: implications for galectin-glycan interactions at the cell surface.

Authors:  Michelle C Miller; Irina V Nesmelova; David Platt; Anatole Klyosov; Kevin H Mayo
Journal:  Biochem J       Date:  2009-06-26       Impact factor: 3.857

4.  Galectin-3 in urine of cancer patients: stage and tissue specificity.

Authors:  Kiruthika Balasubramanian; Raghavendra Vasudevamurthy; Sathisha Upparahalli Venkateshaiah; Anil Thomas; A Vishweshwara; Shylaja Mallaiah Dharmesh
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-03       Impact factor: 4.553

5.  Novel polysaccharide binding to the N-terminal tail of galectin-3 is likely modulated by proline isomerization.

Authors:  Michelle C Miller; Y Zheng; Jingmin Yan; Yifa Zhou; Guihua Tai; Kevin H Mayo
Journal:  Glycobiology       Date:  2017-11-01       Impact factor: 4.313

Review 6.  Modified citrus pectin anti-metastatic properties: one bullet, multiple targets.

Authors:  Vladislav V Glinsky; Avraham Raz
Journal:  Carbohydr Res       Date:  2008-09-26       Impact factor: 2.104

7.  Analysis of the neutral polysaccharide fraction of MCP and its inhibitory activity on galectin-3.

Authors:  Xiaoge Gao; Yuan Zhi; Tao Zhang; Huiting Xue; Xiao Wang; Anthony D Foday; Guihua Tai; Yifa Zhou
Journal:  Glycoconj J       Date:  2012-05-07       Impact factor: 2.916

8.  Modified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injury.

Authors:  Maria Kolatsi-Joannou; Karen L Price; Paul J Winyard; David A Long
Journal:  PLoS One       Date:  2011-04-08       Impact factor: 3.240

Review 9.  Anti-cancer activities of pH- or heat-modified pectin.

Authors:  Lionel Leclere; Pierre Van Cutsem; Carine Michiels
Journal:  Front Pharmacol       Date:  2013-10-08       Impact factor: 5.810

10.  Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and Galactomannans.

Authors:  John Stegmayr; Adriana Lepur; Barbro Kahl-Knutson; Matilde Aguilar-Moncayo; Anatole A Klyosov; Robert A Field; Stina Oredsson; Ulf J Nilsson; Hakon Leffler
Journal:  J Biol Chem       Date:  2016-04-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.